Class information for:
Level 1: AMOXICILLIN SULBACTAM//SULTAMICILLIN//SULBACTAM

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
11084 943 21.8 52%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
434 15650 CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 AMOXICILLIN SULBACTAM Author keyword 13 80% 1% 8
2 SULTAMICILLIN Author keyword 12 56% 2% 15
3 SULBACTAM Author keyword 10 25% 4% 36
4 AMPICILLIN SULBACTAM Author keyword 7 33% 2% 17
5 PIPERACILLIN TAZOBACTAM Author keyword 3 12% 2% 22
6 SULBACTAM AMPICILLIN Author keyword 3 32% 1% 7
7 TAZOBACTAM Author keyword 3 15% 2% 16
8 BETA LACTAMASE INHIBITOR Author keyword 2 17% 1% 12
9 BETA LACTAM BETA LACTAMASE INHIBITOR COMBINATION Author keyword 2 67% 0% 2
10 BETA LACTAMASE INHIBITORS Author keyword 2 15% 1% 13

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 AMOXICILLIN SULBACTAM 13 80% 1% 8 Search AMOXICILLIN+SULBACTAM Search AMOXICILLIN+SULBACTAM
2 SULTAMICILLIN 12 56% 2% 15 Search SULTAMICILLIN Search SULTAMICILLIN
3 SULBACTAM 10 25% 4% 36 Search SULBACTAM Search SULBACTAM
4 AMPICILLIN SULBACTAM 7 33% 2% 17 Search AMPICILLIN+SULBACTAM Search AMPICILLIN+SULBACTAM
5 PIPERACILLIN TAZOBACTAM 3 12% 2% 22 Search PIPERACILLIN+TAZOBACTAM Search PIPERACILLIN+TAZOBACTAM
6 SULBACTAM AMPICILLIN 3 32% 1% 7 Search SULBACTAM+AMPICILLIN Search SULBACTAM+AMPICILLIN
7 TAZOBACTAM 3 15% 2% 16 Search TAZOBACTAM Search TAZOBACTAM
8 BETA LACTAMASE INHIBITOR 2 17% 1% 12 Search BETA+LACTAMASE+INHIBITOR Search BETA+LACTAMASE+INHIBITOR
9 BETA LACTAM BETA LACTAMASE INHIBITOR COMBINATION 2 67% 0% 2 Search BETA+LACTAM+BETA+LACTAMASE+INHIBITOR+COMBINATION Search BETA+LACTAM+BETA+LACTAMASE+INHIBITOR+COMBINATION
10 BETA LACTAMASE INHIBITORS 2 15% 1% 13 Search BETA+LACTAMASE+INHIBITORS Search BETA+LACTAMASE+INHIBITORS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 YTR 830 38 66% 4% 35
2 INHIBITORS YTR 830 15 82% 1% 9
3 CP 45 899 15 71% 1% 12
4 SULBACTAM 13 24% 5% 48
5 TAZOBACTAM YTR 830 11 100% 1% 6
6 SPECTRUM PENICILLINS 9 83% 1% 5
7 SULTAMICILLIN 8 75% 1% 6
8 SULBACTAM AMPICILLIN 8 45% 1% 13
9 COMPARATIVE INVITRO 7 36% 2% 16
10 CLAVULANATE 6 19% 3% 27

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Piperacillin tazobactam: A critical review of the evolving clinical literature 1996 33 49 55%
SULBACTAM AMPICILLIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE 1987 77 55 67%
Rational antibiotic therapy and the position of ampicillin/sulbactam 2008 23 96 42%
Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation 2001 6 39 90%
PIPERACILLIN/TAZOBACTAM - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL 1994 56 90 38%
New formulations of amoxicillin/clavulanic acid - A pharmacokinetic and pharmacodynamic review 2005 7 76 42%
SULBACTAM AMPICILLIN - INVITRO SPECTRUM, POTENCY, AND ACTIVITY IN MODELS OF ACUTE INFECTION 1986 70 5 80%
Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections 2001 7 44 61%
SULTAMICILLIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE 1989 32 35 80%
PHARMACOKINETICS OF SULBACTAM AMPICILLIN IN HUMANS - A REVIEW 1986 60 29 90%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 GOOD CLIN PRACTICES 1 50% 0.2% 2
2 IKUDEKAM 1 100% 0.2% 2
3 ANTIBIOL 1 13% 0.6% 6
4 AREA PHYSIOL PATHOPHYSIOL 1 50% 0.1% 1
5 JHARMAJRI EPIP 1 50% 0.1% 1
6 PHARM EDUC PHARMACOTHER Y 1 50% 0.1% 1
7 CASILLA 2407 0 20% 0.2% 2
8 GESELL PHARMAKOKINET 0 20% 0.2% 2
9 COSTARRICENSE INVEST CLIN 0 33% 0.1% 1
10 POST COURSE PHARMACEUT SCI 0 33% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000162822 NAGZ//AMPG//AMPR
2 0.0000145994 AZLOCILLIN//MEZLOCILLIN//ANIMAL MODELS ALTERNATIVES
3 0.0000107167 CFIA//BACTEROIDES FRAGILIS//NIM GENES
4 0.0000104423 VET BASIC MED SCI//CYCLOSPORINE METABOLISM//DOSE REGIME
5 0.0000103795 BETA LACTAMASE//INGN PROT//DD PEPTIDASE
6 0.0000094510 TEMOCILLIN//AFDELING MED MICROBIOL INFECTIEZIEKTEN//P OFF
7 0.0000092804 BURNS TRAUMA CRIT CARE//MUTANT SELECTION WINDOW//ANTIINFECT DEV
8 0.0000085471 CAS 58001 44 8//HOSPITAL PATHOGENS//RV3676
9 0.0000083581 RUMINANT DIS EPIDEMIOL//SUCTION BLISTER METHOD//SKIN BLISTER FLUID CONCENTRATION
10 0.0000071407 TERTIARY PERITONITIS//MANNHEIM PERITONITIS INDEX//SECONDARY PERITONITIS